18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor-Reference-Cited by-同舟云学术

18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor

Published:2017-06-08 Issue:1 Volume:59 Page:15-24
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Dercle Laurent,Seban Romain-David,Lazarovici Julien,Schwartz Lawrence H.,Houot Roch,Ammari Samy,Danu Alina,Edeline Véronique,Marabelle Aurélien,Ribrag Vincent,Michot Jean-Marie

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

2. Armand P Shipp MA Ribrag V . Programmed death-1 blockade with pembrolizumab in patients with classical Hodgkin lymphoma after brentuximab vedotin failure. J Clin Oncol. June 27, 2016 [Epub ahead of print].

3. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

4. The biology of Hodgkin's lymphoma

5. Immunologic pathomechanism of Hodgkin’s lymphoma;Jona;Exp Hematol.,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation;EJNMMI Research;2024-08-28

2. Fluorine-18 fluorodeoxyglucose uptake change in liver, mediastinal blood pool, and lymphoid cell–rich organs during programmed cell death-1 immunotherapy in lymphoma;Nuclear Medicine Communications;2024-05-10

3. PET/Computed Tomography Transformation of Oncology;PET Clinics;2024-04

4. The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management;Advanced Pharmaceutical Bulletin;2024-03-10

5. Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas;Cancers;2023-09-21